They demonstrated that the inhibition of the interaction between the BCR-ABL1 CC and HSP90AB1 relocalizes BCR-ABL1 to the nucleus, triggering apoptosis in CML cells. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.